Advertisement
Screener

MusclePharm Corporation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture

MusclePharm Corporation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture

MusclePharm Corporation reported Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture of $300.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.

Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement

us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation · last filed 2018-11-14

  • MusclePharm Corporation shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2018-09-30 was $300.00K, a 0.00% change year-over-year.
  • MusclePharm Corporation shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
  • MusclePharm Corporation shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
  • MusclePharm Corporation shares granted, value, share-based payment arrangement, after forfeiture for the quarter ending 2017-09-30 was $300.00K.
Period endShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 monthShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 3 month as first filedShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 6 monthShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 monthShares Granted, Value, Share-based Payment Arrangement, after Forfeiture 9 month as first filed
2018-09-30$300.00K
10-Q · filed 2018-11-14
$300.00K
derived: sum of 2 quarters · filed 2018-11-14
$300.00K
10-Q · filed 2018-11-14
2018-06-30$0.00
10-Q · filed 2018-08-14
$0.00
10-Q · filed 2018-08-14
2018-03-31$0.00
10-Q · filed 2018-05-15
2017-09-30$300.00K
10-Q · filed 2018-11-14
$168.78M
10-Q · filed 2017-11-14
$400.00K
derived: sum of 2 quarters · filed 2018-11-14
$1.00M
10-Q · filed 2018-11-14
$538.95M
10-Q · filed 2017-11-14
2017-06-30$100.00K
10-Q · filed 2018-08-14
$20.16M
10-Q · filed 2017-08-14
$700.00K
10-Q · filed 2018-08-14
2017-03-31$700.00K
10-Q · filed 2018-05-15